search icon
Join IDSAJOIN IDSA >> Go to MyIDSAGO TO MYIDSA >>
  • What's New in Practice Management & Payment

    CMS Releases 2018 Medicare Physician Fee Schedule Proposed Rule

    CMS: Fact Sheet for the QPP Year 2 Proposed Rule

    AMA Releases New MIPS Resources

    CMS Releases Lookup Tool to Help Clinicians Determine their MIPS Participation Status

    CMS: New Quality Payment Program Resources Available

  • Upcoming Meetings

    IDWeek 2017 logo
    August 26 - 30, 2017 | Tysons Corner, VA

    2017 Infectious Disease Board Review Course

  • News from IDSA and Journals

    Ebola RNA Detected in Semen Two Years After Disease Onset

    Read More >>

    Among 137 male survivors who donated semen two years after onset of their disease, 11 (8 percent) had a specimen positive for Ebola virus RNA, according to a new OFID study.

     

  • CDC and FDA Alerts

    8/7/2017 5:39:15 PM

    Increase in Reported cases of Cyclospora cayetanensis Infection, United States, Summer 2017

    The Centers for Disease Control and Prevention (CDC), State and Local Health Departments, and theFood and Drug Administration (FDA) are investigating an increase in reported cases of cyclosporiasis.

    8/4/2017 11:52:44 AM

    FDA Approves Mavyret for Hepatitis C

     The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis. 

    7/21/2017 10:41:19 AM

    CDC Investigation Announcement regarding Salmonella Typhimurium infections linked to exposure to clinical and teaching microbiology laboratories

    CDC and public health officials in several states have identified a multistate outbreak of Salmonella Typhimurium infections linked to various clinical, commercial, and college and university teaching microbiology laboratories.

    7/19/2017 12:06:16 PM

    CDC call for cases of NTM following cosmetic surgery in the Dominican Republic

    Several state and local health departments are investigating recent cases of nontuberculous mycobacteria surgical site infections (e.g., Mycobacterium abscessus, Mycobacterium massiliense) associated with cosmetic surgery received in the Dominican Republic.

    7/18/2017 5:01:10 PM

    FDA approves new drug to treat adults with chronic hepatitis C virus genotypes 1-6 without cirrhosis or with mild cirrhosis

    The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.

    7/10/2017 2:52:14 PM

    Patients Receiving Eculizumab (Soliris®) at High Risk for Invasive Meningococcal Disease Despite Vaccination

    Eculizumab (Soliris®) recipients have a 1,000 to 2,000-fold greater risk of invasive meningococcal disease compared to the general U.S. population. 

    7/10/2017 12:26:19 PM

    IDSA Statement on the Appointment of Dr. Brenda Fitzgerald as Director of CDC

    IDSA Statement on the Appointment of Dr. Brenda Fitzgerald as Director of CDC   The Infectious Diseases Society of America congratulates Dr. Brenda Fitzgerald on her appointment to lead the Centers for Disease Control and Prevention at this critical time.  Strong federal public health leadership will be essen

    7/7/2017 3:18:56 PM

    FDA approves new fluoroquinolone antibiotic to treat bacterial skin infections

    The U.S. Food and Drug Administration today approved Baxdela (delafloxacin), a new antibacterial drug to treat acute bacterial skin and skin structure infections. Baxdela is available for intravenous and oral use.

  • Policy News

    8/4/2017

    Leaders urge NIH to make the most of NGRI

    IDSA, HIVMA, PIDS offer feedback to National Institutes of Health on Next Generation Research Initiative

| HIVMA | Contact Us

© Copyright IDSA 2017 Infectious Diseases Society of America

Full Site Mobile Site